Drug Price Trends for HM MOTION SICKNESS

Average Pharmacy Cost for HM MOTION SICKNESS

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
HM MOTION SICKNESS 50 MG TAB	62011-0341-01	0.07107	EACH	2025-01-22
HM MOTION SICKNESS 50 MG TAB	62011-0341-01	0.06943	EACH	2024-12-18
HM MOTION SICKNESS 50 MG TAB	62011-0341-01	0.08295	EACH	2024-11-20
HM MOTION SICKNESS 50 MG TAB	62011-0341-01	0.07031	EACH	2024-10-23
HM MOTION SICKNESS 50 MG TAB	62011-0341-01	0.06276	EACH	2024-09-18
HM MOTION SICKNESS 50 MG TAB	62011-0341-01	0.06401	EACH	2024-08-21
HM MOTION SICKNESS 50 MG TAB	62011-0341-01	0.07602	EACH	2024-07-17

Motion Sickness Treatment Market Analysis and Projections

Market Overview

The global motion sickness treatment market is experiencing significant growth, driven by several key factors. The market was valued at $393.7 million in 2021 and is projected to reach $525 million by 2031, growing at a CAGR of 2.9% from 2022 to 2031[1].

Key Drivers of Market Growth

• Increasing Incidence of Motion Sickness: Motion sickness affects a substantial portion of the population, with around 10% being more prone to it than others. This rise in incidence is a major driver of the market[1].
• Emerging Markets and Healthcare Infrastructure: The availability of improved healthcare infrastructure and the surge in demand for effective motion sickness medications in emerging markets such as China, India, and Brazil are significant growth drivers[1][3].
• Product Approvals and Technological Advancements: Recent approvals for generic and branded versions of transdermal patches and other medications have increased the adoption of these treatments. Technological advancements in production and formulation development have also enhanced the efficacy and quality of medications[1].

Market Segmentation

By Treatment Type

• Antihistamines: This segment held the largest global market share in 2021 and is expected to remain dominant due to their low cost, over-the-counter availability, and effectiveness in reducing motion sickness symptoms[1].
• Anticholinergics: This segment is anticipated to grow at the fastest rate during the forecast period, driven by the effectiveness of anticholinergic drugs, particularly scopolamine transdermal patches[1].

By Route of Administration

• Oral: The oral route of administration accounts for the largest market share due to its ease of use and widespread availability[4].
• Transdermal: Transdermal patches, such as scopolamine patches, are gaining popularity due to their effectiveness and convenience[1].

By Distribution Channel

• Retail Pharmacies: Retail pharmacies remain a major distribution channel, but online pharmacies are increasingly gaining traction due to their convenience and accessibility[4][5].

Geographical Landscape

• North America: This region is expected to witness the highest growth in terms of revenue, driven by increased awareness among the population regarding motion sickness management and a large number of travelers[1].
• Asia-Pacific: This region is anticipated to witness notable growth due to economic growth, urbanization, and the rising number of travelers. Countries like China, India, and Brazil offer significant growth opportunities[1][3].

Market Size and Projections

• The global motion sickness treatment market is projected to grow from $393.7 million in 2021 to $525 million by 2031, at a CAGR of 2.9%[1].
• Another forecast suggests the market could reach $876.8 million by 2030, growing at a CAGR of 3.4% from 2023 to 2030[2].

Key Players

• Sun Pharmaceutical Industries Ltd.
• WellSpring Pharmaceutical Corporation
• Prestige Consumer Healthcare Inc.
• Perrigo Company, PLC
• Myungmoon Pharm Co., Ltd.
• Reliefband Technologies LLC
• GlaxoSmithKline
• Novartis
• Teva Pharmaceuticals[1][3][5].

Consumer Awareness and Promotional Activities

• Increased consumer awareness about preventive healthcare and the ease of accessibility of medications are boosting the adoption of motion sickness treatments. Promotional activities by manufacturers for new products are also expected to fuel their adoption during the forecast period[1].

Technological and Research Advancements

• The emergence of nauseogenic information technology and expanding research on psychosomatic disorders are expected to contribute to substantial market demand in the coming years[5].

Challenges and Opportunities

• While the market is driven by several positive factors, it also faces challenges such as side effects associated with certain medications and the need for more effective treatments. However, these challenges also present opportunities for innovation and the development of new, more effective treatments[1][3].

Price Projections and Market Sizing

The price projections for motion sickness treatments are influenced by several factors, including the type of medication, route of administration, and geographical location.

• Generic vs. Branded Medications: Generic medications, such as antihistamines, are generally more affordable and widely available, contributing to their dominant market share[1].
• Transdermal Patches: These are often more expensive than oral medications but offer convenience and effectiveness, which can justify the higher cost[1].

Given the projected market growth, it is likely that prices will remain competitive, with a focus on balancing affordability with the quality and efficacy of the treatments.

Key Takeaways

• The global motion sickness treatment market is growing steadily, driven by increasing incidence, emerging markets, and technological advancements.
• Antihistamines and anticholinergics are the dominant treatment types.
• North America and Asia-Pacific are key regions driving market growth.
• Consumer awareness and promotional activities are crucial for market expansion.
• Technological advancements and research on psychosomatic disorders will continue to shape the market.

Frequently Asked Questions

Q: What is the current size of the global motion sickness treatment market?

• The global motion sickness treatment market was valued at $393.7 million in 2021[1].

Q: What is the projected growth rate of the motion sickness treatment market?

• The market is expected to grow at a CAGR of 2.9% from 2022 to 2031[1].

Q: Which segment holds the largest market share in the motion sickness treatment market?

• The antihistamines segment holds the largest market share due to its low cost, over-the-counter availability, and effectiveness[1].

Q: What are the key drivers of the motion sickness treatment market?

• Key drivers include the increasing incidence of motion sickness, emerging markets, and technological advancements in medication production[1][3].

Q: Which regions are expected to witness significant growth in the motion sickness treatment market?

• North America and Asia-Pacific are expected to witness significant growth due to increased awareness and a rising number of travelers[1][3].

Sources:

1. Allied Market Research - Motion Sickness Treatment Market Research, 2031
2. IndustryARC - Motion Sickness Treatment Market - Forecast(2024 - 2030)
3. Transparency Market Research - Motion Sickness Treatment Market Analysis Report 2026
4. Maximize Market Research - Motion Sickness Treatment Market: Global Industry Analysis and ...
5. PR Newswire - Key Players in Motion Sickness Drugs Market Include ...